Editas Medicine (EDIT) PT Lowered to $8 at Baird
Tweet Send to a Friend
(Updated - December 13, 2024 6:53 AM EST)
Baird analyst Joel Beatty lowered the price target on Editas Medicine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty lowered the price target on Editas Medicine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
